The success of Sildenafil initially sparked a period of growth for the drug industry, but recent shifts present a complicated outlook for shareholders. Lower-cost competitors are eating into revenue, and continued https://joycecvlf047329.blogerus.com/63159964/viagra-and-big-pharma-a-precarious-investment